Cytokinetics, Incorporated Business Finance Contracts & Agreements

57 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Common Stock Option and Purchase Agreement, dated May 22, 2024, by and between Royalty Pharma Investments 2019 ICAV and the Company
Stock Agreements
Cytokinetics, Incorporated
Biotechnology
MA
2024
CK-586 Revenue Participation Right Purchase Agreement, dated May 22, 2024, by and between Royalty Pharma Investments 2019 ICAV and the Company
Purchase Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2024
2024 Development Funding Loan Agreement, dated May 22, 2024, by and among Royalty Pharma Development Funding, LLC and the Company
Loan Agreements
Cytokinetics, Incorporated
Biotechnology
NY
2024
Amendment No. 1, dated May 22, 2024, to Revenue Participation Right Purchase Agreement, dated January 7, 2022, by and between Royalty Pharma Investments 2019 ICAV and the Company
Purchase Agreements
Cytokinetics, Incorporated
Biotechnology
NY
2024
Third Amendment, dated May 22, 2024, to Development Funding Loan Agreement, dated January 7, 2022, by and among Royalty Pharma Development Funding, LLC and the Company
Loan Agreements
Cytokinetics, Incorporated
Biotechnology
NY
2024
Underwriting Agreement, dated as of May 22, 2024, by and among Cytokinetics, Incorporated, J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC
Underwriting Agreements
Cytokinetics, Incorporated
Biotechnology
2024
Cytokinetics, Incorporated Amended and Restated 2015 Employee Stock Purchase Plan
Stock Agreements
Cytokinetics, Incorporated
Biotechnology
2024
Indenture, dated as of July 6, 2022, between Cytokinetics, Incorporated and U.S. Bank Trust Company, National Association, as trustee
Indenture Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2022
Revenue Participation Right Purchase Agreement, dated January 7, 2022, by and between the Company and Royalty Pharma Investments 2019 ICAV
Purchase Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2022
Amendment No. 1 to Royalty Purchase Agreement, dated January 7, 2022, by and between the Company and RPI Finance Trust
Purchase Agreements
Cytokinetics, Incorporated
Biotechnology
2022
Development Funding Loan Agreement, dated January 7, 2022, by and among Royalty Pharma Development Funding, LLC and the Company
Loan Agreements
Cytokinetics, Incorporated
Biotechnology
NY
2022
Common Stock Purchase Agreement, dated December 20, 2021, by and between the Company and RTW Venture Fund Limited
Stock Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2022
Common Stock Purchase Agreement, dated December 20, 2021, by and between the Company and RTW Innovation Master Fund, Ltd
Stock Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2022
Common Stock Purchase Agreement, dated December 20, 2021, by and between the Company and RTW Master Fund, Ltd
Stock Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2022
Fourth Amendment to Loan and Security Agreement, dated June 30, 2021, by and among the Company, Oxford Finance LLC and Silicon Valley Bank
Loan Agreements
Cytokinetics, Incorporated
Biotechnology
2021
Underwriting Agreement, dated as of July 20, 2021, by and among Cytokinetics, Incorporated, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC
Underwriting Agreements
Cytokinetics, Incorporated
Biotechnology
2021
Third Amendment to Loan and Security Agreement, dated July 16, 2020, by and among the Company, Oxford Finance LLC and Silicon Valley Bank
Loan Agreements
Cytokinetics, Incorporated
Biotechnology
2020
Form of Common Stock Purchase Agreement, dated July 14, 2020
Stock Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2020
Royalty Purchase Agreement, dated July 14, 2020, by and between the Company and Dolya Holdco 19 Designated Activity Company
Purchase Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2020
Funding Agreement, dated July 14, 2020, by and between the Company and Dolya Holdco 19 Designated Activity Company
Funding Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2020
Underwriting Agreement, dated as of July 16, 2020, by and among Cytokinetics, Incorporated, Goldman Sachs & Co. LLC, Piper Sandler & Co. and Cantor Fitzgerald & Co
Underwriting Agreements
Cytokinetics, Incorporated
Biotechnology
2020
Second Amendment to Loan and Security Agreement, dated as of November 7, 2019, by and among the Company, Oxford Finance LLC and Silicon Valley Bank
Loan Agreements
Cytokinetics, Incorporated
Biotechnology
2019
First Amendment to Loan and Security Agreement, dated as of November 6, 2019, by and among the Company, Oxford Finance LLC and Silicon Valley Bank
Loan Agreements
Cytokinetics, Incorporated
Biotechnology
2019
First Supplemental Indenture, dated November 13, 2019, between the Company and U.S. Bank National Association, as Trustee (including the form of 4.00% Convertible Senior Note due...
Indenture Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2019
Base Indenture, dated November 13, 2019, between the Company and U.S. Bank National Association, as Trustee
Indenture Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2019
Underwriting Agreement, dated November 7, 2019, by and between the Company and Morgan Stanley & Co. LLC as representative of the several underwriters named therein
Underwriting Agreements
Cytokinetics, Incorporated
Biotechnology
NY
2019
Loan and Security Agreement, dated as of May 17, 2019, by and among the Company, Oxford Finance LLC and Silicon Valley Bank
Loan Agreements
Cytokinetics, Incorporated
Biotechnology
CA
2019
Form of Warrant Issuable to Silicon Valley Bank
Warrant Agreements
Cytokinetics, Incorporated
Biotechnology
CA
2019
Form of Warrant Issuable to Oxford Finance LLC
Warrant Agreements
Cytokinetics, Incorporated
Biotechnology
CA
2019
Second Amendment to Loan and Security Agreement by and among the Company, Oxford Finance LLC and Silicon Valley Bank, dated as of October 27, 2017
Loan Agreements
Cytokinetics, Incorporated
Biotechnology
2018
5,260,000Shares of Common Stock CYTOKINETICS, INCORPORATED UNDERWRITING AGREEMENT
Underwriting Agreements
Cytokinetics, Incorporated
Biotechnology
NY
2017
CYTOKINETICS, INCORPORATED COMMON STOCK PURCHASE AGREEMENT
Stock Agreements
Cytokinetics, Incorporated
Biotechnology
NY
2017
ROYALTYPURCHASE AGREEMENT BY AND BETWEEN CYTOKINETICS, INCORPORATED AND RPIFINANCE TRUST DATED AS OF FEBRUARY 1, 2017 TABLE OF CONTENTS
Trust Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2017
LOAN ANDSECURITY AGREEMENT
Loan Agreements
Cytokinetics, Incorporated
Biotechnology
CA
2016
WARRANT TO PURCHASESTOCK
Warrant Agreements
Cytokinetics, Incorporated
Biotechnology
CA
2016
CYTOKINETICS, INCORPORATED Shares of Common Stock (par value$0.001 per share) Controlled Equity OfferingSM Sales Agreement
Stock Agreements
Cytokinetics, Incorporated
Biotechnology
NY
2015
CYTOKINETICS, INCORPORATED 2015 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:FEBRUARY 3, 2015 APPROVED BY THE STOCKHOLDERS:MAY 20, 2015 EFFECTIVE DATE: NOVEMBER...
Stock Agreements
Cytokinetics, Incorporated
Biotechnology
2015
CYTOKINETICS, INCORPORATED COMMON STOCK PURCHASE AGREEMENT
Stock Agreements
Cytokinetics, Incorporated
Biotechnology
NY
2014
4,375,000 Shares of Common Stock CYTOKINETICS, INCORPORATED UNDERWRITING AGREEMENT
Underwriting Agreements
Cytokinetics, Incorporated
Biotechnology
NY
2014
CYTOKINETICS, INCORPORATED 2004 EMPLOYEE STOCK PURCHASE PLAN (As amended by the Board of Directors on February 6, 2013; stockholder approval May 22, 2013; updated following...
Purchase Agreements
Cytokinetics, Incorporated
Biotechnology
2013